Lucy Pérez is a Senior Partner in McKinsey & Company’s Boston office, Coleader of the McKinsey Health Institute, and a leader of the Life Sciences practice. She advises CEOs and teams at leading organizations globally on growth strategy, innovation, sustainability, and organizational transformation. Lucy is especially passionate about leveraging advancements in science and technology to transform patient care delivery and health outcomes. A former cancer researcher at Memorial Sloan-Kettering Cancer Center, she brings a strong technical background to her work with organizations across the healthcare sector. Lucy also co-leads McKinsey’s Hispanic and Latino Network for colleagues who identify as Hispanic, Latino, or allies, and sponsors research on Latino economic mobility.
At the McKinsey Health Institute, Lucy spearheads efforts to advance health equity, including a collaboration with the World Economic Forum on the $1 trillion health and economic opportunity to close the women’s health gap. This seminal research has reached millions, received a Presidential Award from the American Medical Women’s Association, and is driving action among stakeholders across the globe.
Beyond her work at McKinsey, Lucy is a board member of the Massachusetts Business Roundtable and sits on the advisory board for the Aspen Institute’s Latinos in Society program and the Women’s Health Innovation Summit. Lucy was elected one of Amplify LatinX’s inaugural LatinX 100 Leaders and named one of ALPFA’s 50 Most Powerful Latinas in 2023. She was awarded the Pinnacle Award by the Boston Chamber of Commerce in 2024, which recognizes women leaders who are changing Greater Boston through leadership excellence in entrepreneurship, management and lifetime achievement.
Lucy holds a bachelor’s degree and doctorate degree in Chemistry from Harvard University. She is an avid traveler, amateur photographer, and a co-inventor on multiple patents.
Published work
“Decarbonizing API manufacturing: Unpacking the cost and regulatory requirements,” McKinsey & Company, July 2024
“The state of US women’s heart health: A path to improved health and financial outcomes,” McKinsey Health Institute, June 2024
“Bridging the women’s health gap: A country-level exploration,” McKinsey Health Institute, May 2024
“Are women’s prime working years in peril?,” McKinsey & Company, March 2024
“Mapping the road to prosperity and parity for Black and Latino residents across America,” McKinsey & Company, March 2024
“Latinos in Hollywood: Amplifying voices, expanding horizons,” McKinsey & Company, March 2024
“Accelerating diversity in clinical trials,” McKinsey Institute for Black Economic Mobility, February 2024
“Closing the women’s health gap: A $1 trillion opportunity to improve lives and economies,” McKinsey Health Institute, January 2024
“Courageous growth: Six strategies for continuous growth outperformance,” McKinsey & Company, October 2023
“Accelerating the transition to net zero in life sciences,” McKinsey & Company, August 2023
“The triple play: Growth, profit, and sustainability,” McKinsey & Company, August 2023
“Closing the data gaps in women’s health,” McKinsey & Company, April 2023
“The economic state of Latinos in the US: Determined to thrive,” McKinsey & Company, November 2022
“How to make ESG real,” ,” McKinsey Quarterly, August 2022
“Does ESG really matter—and why?,” McKinsey Quarterly, August 2022
“Digital health: An opportunity to advance health equity,” McKinsey & Company, July 2022
“Self-learning: The dawn of a new biomedical R&D paradigm,” McKinsey & Company, July 2022
“What will it take to boost Latino economic power?,” McKinsey & Company, May 2022
“Better data for better therapies: The case for building health data platforms,” McKinsey & Company, April 2022
“Health equity: A framework for the epidemiology of care,” McKinsey & Company, March 2022
“The dawn of the FemTech revolution,” McKinsey & Company, February 2022
“Unlocking opportunities in women’s healthcare,” McKinsey & Company, February 2022
The economic state of Latinos in America: The American dream deferred, McKinsey & Company, December 2021
“Integrated evidence generation: A paradigm shift in biopharma,” McKinsey & Company, November 2021
“US Hispanic and Latino lives and livelihoods in the recovery from COVID-19,” McKinsey & Company, September 2020
“Creating value from next-generation real-world evidence,” McKinsey & Company, July 2020
Education
Harvard University
PhD, chemistry
AB, chemistry